We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
476
Tandem Capital Management
New Jersey
$4.87M -$53.3K -605 -1%
SP
477
Saranac Partners
$4.78M -$212K -2,412 -4%
Jane Street
478
Jane Street
New York
$4.7M -$15.8M -179,830 -77%
LFG
479
Larson Financial Group
Missouri
$4.68M +$405K +4,599 +10%
BFG
480
Bleakley Financial Group
New Jersey
$4.68M +$1.13M +12,788 +32%
LWMM
481
Legacy Wealth Management (Mississippi)
Mississippi
$4.67M -$291K -3,310 -6%
P
482
&Partners
Tennessee
$4.63M +$1.3M +14,771 +41%
CG
483
Caprock Group
Idaho
$4.63M +$469K +5,323 +11%
JWM
484
Jackson Wealth Management
Florida
$4.62M +$4.21M +47,791 +1,201%
LOAMS
485
Lombard Odier Asset Management (Switzerland)
Switzerland
$4.57M +$404K +4,588 +10%
Nomura Holdings
486
Nomura Holdings
Japan
$4.54M +$2.18M +24,768 +95%
CL
487
Choreo LLC
Illinois
$4.54M +$1.69M +19,187 +61%
ACM
488
Aubrey Capital Management
United Kingdom
$4.52M +$123K +1,400 +3%
SPIA
489
Steward Partners Investment Advisory
New York
$4.52M +$38.1K +433 +0.9%
WHGC
490
Wealth High Governance Capital
Brazil
$4.44M +$4.38M +49,750 New
ECM
491
Everence Capital Management
Indiana
$4.44M +$596K +6,770 +16%
PP
492
Prudential plc
United Kingdom
$4.41M +$1.05M +11,911 +32%
SI
493
Sava Infond
Slovenia
$4.4M +$4.34M +49,310 New
SFI
494
Siemens Fonds Invest
Germany
$4.39M +$101K +1,153 +2%
EF
495
Empirical Finance
Pennsylvania
$4.38M -$54.5K -619 -1%
CPC
496
Consolidated Planning Corp
Georgia
$4.36M +$89.6K +1,018 +2%
CAL
497
Capital Analysts LLC
Pennsylvania
$4.34M +$64.1K +728 +2%
Cambridge Investment Research Advisors
498
Cambridge Investment Research Advisors
Iowa
$4.32M +$925K +10,504 +28%
VIM
499
Vinva Investment Management
Australia
$4.26M -$404K -4,586 -9%
SC
500
Stance Capital
Massachusetts
$4.22M +$4.16M +47,255 New

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.